Subscribe: Biotechnology
http://rss.prnewswire.com/industry/bio
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
aug prnewswire  aug  august prnewswire  august  based  butanol market  company  development  global  market  prnewswire  research  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Biotechnology

PR Newswire: Biotechnology



Press Releases from PR Newswire about Biotechnology



Published: Sun, 20 Aug 2017 07:31:36 EDT

Last Build Date: Fri, 18 Aug 2017 14:45:00 EDT

 



Biopharmaceutical CMO & CRO Market to Value $37.8 Billion by 2025: Regional Estimates & Trend Analysis, by Service, Source, & Product

Fri, 18 Aug 2017 14:45:00 EDT

(image) DUBLIN, August 18, 2017 /PRNewswire/ -- The "Biopharmaceutical CMO & CRO Market, 2014 - 2025" report has been added to Research and Markets' offering. The global biopharmaceutical CMO & CRO (contract manufacturing & research) market is expected to reach USD 37.8...



Media Files:
http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg




MiMedx Signs Definitive Agreement to Divest Stability Biologics Subsidiary as Part of Company's Strategic Focus on Biopharma

Fri, 18 Aug 2017 14:05:00 EDT

(image) MARIETTA, Ga., Aug. 18, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of...



Media Files:
http://www.mimedx.com




As iPads become Commonplace in Field Roles in the Pharmaceutical Industry, Tablet Utilization has not Translated to Increased Effectiveness, New Study Finds

Fri, 18 Aug 2017 13:22:00 EDT

(image) CHAPEL HILL, N.C., Aug. 18, 2017 /PRNewswire/ -- Across the pharmaceutical industry, iPads have become commonplace for field-based medical roles such as medical science liaisons (MSLs) that present scientific information to thought leaders and other physicians. This technology shift -...



Media Files:
http://www.best-in-class.com




Global Cell Line Development Services Markets, 2017-2025 - Stringent and Complex Regulations for Biologics in North America and Europe

Fri, 18 Aug 2017 11:30:00 EDT

(image) DUBLIN, August 18, 2017 /PRNewswire/ -- The "Cell Line Development Services Global Market - Forecast to 2025" report has been added to Research and Markets' offering. The cell line development service market is expected to grow at double digit CAGR to reach $1,214.7 million by...



Media Files:
http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg




BiologicTx® MatchGrid Powered Largest Ever Kidney Exchange In State Of Connecticut At Yale New Haven Hospital

Fri, 18 Aug 2017 11:22:00 EDT

(image) TOTOWA, N.J., Aug. 18, 2017 /PRNewswire/ -- BiologicTx®, a member of the BioMatrix SpRx family of companies, today announced that their kidney paired donation software, BiologicTx MatchGrid™, was the matching software utilized for a successful 9-way kidney exchange at the Yale...



Media Files:
https://mma.prnewswire.com/media/546678/BiologicTx_Logo.jpg




Nortis Awarded $688K NIH Phase II SBIR Fast Track Grant to Develop Living Model of Human Blood-Brain Barrier

Fri, 18 Aug 2017 08:45:00 EDT

(image) SEATTLE, Aug. 18, 2017 /PRNewswire/ -- Nortis today announced the awarding of a $688K National Institutes of Health (NIH) grant. The award will provide funding for the third year of a Small Business Innovation Research (SBIR) Fast-track grant under award numbe...



Media Files:
https://mma.prnewswire.com/media/546512/Nortis_ParVivo_Chip.jpg




Champions Oncology Announces Research Collaboration with The Addario Lung Cancer Medical Institute to Develop Unique Cohort of Patient-Derived Xenograft (PDX) Models

Fri, 18 Aug 2017 08:30:00 EDT

(image) HACKENSACK, N.J., Aug. 18, 2017 /PRNewswire/ -- Champions Oncology, Inc. (NASDAQ: CSBR), a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced a collaboration with The Addario...



Media Files:
http://www.championsoncology.com




Patients Suspected of Sepsis No Longer Need to Wait 5 Days to Rule out Bloodstream Infection with Momentum Bioscience's ETGA® Technology

Fri, 18 Aug 2017 08:24:00 EDT

CARDIFF, Wales, August 18, 2017 /PRNewswire/ -- A study showing how rapid negative exclusion of blood cultures by a molecular method, Cognitor® Minus, can aid antimicrobial stewardship. UK study in general blood culture of 246 patients with suspected sepsis. In 74% of cases...



Windtree Announces Initiation of Financial Restructuring Program

Fri, 18 Aug 2017 07:45:00 EDT

(image) WARRINGTON, Pa., Aug. 18, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has initiated a financial restructuring program intended to result...



Media Files:
http://www.windtreetx.com




Biotech Stocks on Investors' Radar -- Ocular Therapeutix, Omeros, OvaScience, and Regulus Therapeutics

Fri, 18 Aug 2017 07:05:00 EDT

NEW YORK, August 18, 2017 /PRNewswire/ -- If you want a Stock Review on OCUL, OMER, OVAS, or RGLS then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Thursday, August 17, 2017, US markets saw broad based losses with nine out...



DSM - Repurchase of Shares (14 - 17 August 2017)

Fri, 18 Aug 2017 03:01:07 EDT

(image) HEERLEN, The Netherlands, August 18, 2017 /PRNewswire/ -- Royal DSM, a global science-based company active in health, nutrition and materials, has repurchased 100,017 of its own shares in the period from 14 August 2017 up to and including 17 August 2017 at an average price of...



Media Files:
http://photos.prnewswire.com/prn/20160803/395298LOGO




Medivir Initiates Clinical Study of Birinapant in Combination With KEYTRUDA® (Pembrolizumab) in Patients With Treatment-refractory Solid Tumours

Fri, 18 Aug 2017 02:48:00 EDT

STOCKHOLM, Aug 18, 2017 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the first patient has been enrolled in the company's phase I/II study of birinapant in combination with the anti-PD-1 therapy KEYTRUDA® (pembrolizumab), which is marketed by MSD (known as...



Medivir Licenses Exclusive Rights to MIV-802 for Greater China to Ascletis

Fri, 18 Aug 2017 02:32:00 EDT

STOCKHOLM and HANGZHOU, China, Aug 18, 2017 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) and Ascletis today announce that Ascletis has licensed the exclusive rights to develop, manufacture and commercialize Medivir's nucleotide polymerase inhibitor for hepatitis C, MIV-802...



Scientific Research And Development Services Market Global Report 2017

Thu, 17 Aug 2017 19:25:00 EDT

(image) LONDON, Aug. 17, 2017 /PRNewswire/ -- The scientific research and development services industry comprises establishments engaged in research and experimental development on a contract, consultancy or outsourced basis in the areas such as biotechnology, physical sciences, engineering...



Media Files:
http://www.reportbuyer.com




Biobanking Market 2017 - Global Forecast to 2022 - Advances in Biobanking and Growing Trend of Conserving Cord Blood Stem Cells of Newborns

Thu, 17 Aug 2017 18:00:00 EDT

(image) DUBLIN, August 17, 2017 /PRNewswire/ -- The "Biobanking Market by Product and Service(Equipment, Consumable, Services, Software), Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acid), Application(Regenerative Medicine, Life Science, Clinical Research) - Global...



Media Files:
http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg




MiMedx Provides Update on Litigation with Terminated Employees

Thu, 17 Aug 2017 11:58:00 EDT

(image) MARIETTA, Ga., Aug. 17, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of...



Media Files:
http://www.mimedx.com




Analyzing the Financial Health of Biotech Companies

Thu, 17 Aug 2017 11:00:00 EDT

LAS VEGAS, August 17, 2017 /PRNewswire/ -- The business and technology behind the biotechnology industry is multifaceted and uncertain. This makes analyzing a biotech company's future success a challenging job. What makes this task even more difficult is the fact that many biotech...



Mylan Finalizes Settlement Agreement on Medicaid Rebate Classification for EpiPen® Auto-Injector

Thu, 17 Aug 2017 10:43:00 EDT

(image) HERTFORDSHIRE, England and PITTSBURGH, Aug. 17, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that its subsidiaries, Mylan Inc. and Mylan Specialty L.P., have signed an agreement with the U.S. Department of Justice ("DOJ") and two relators finalizing the Medicaid...



Media Files:
https://mma.prnewswire.com/media/521089/Mylan_BHBW_Logo.jpg




Global Bio-based Butanol Market 2017-2021 - Carbon-Negative Bio-Based Butanol Market / Increasing Number of Strategic Alliances / Blending Regulations by Government

Thu, 17 Aug 2017 10:00:00 EDT

(image) DUBLIN, August 17, 2017 /PRNewswire/ -- The "Global Bio-based Butanol Market 2017-2021" report has been added to Research and Markets' offering. The global bio-based butanol market to grow at a CAGR of 9.27% during the period 2017-2021. Global Bio-based Butanol Market...



Media Files:
http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg




HER2 Antibodies Market to Reach US$ 21,669.1 Million by 2025; Perjeta and Other Promising Pipeline Drugs Augur well for Future

Thu, 17 Aug 2017 09:30:00 EDT

ALBANY, New York, August 17, 2017 /PRNewswire/ -- A recent market intelligence study by Transparency Market Research (TMR) suggests that the global HER2 antibodies market offers lucrative opportunities as the awareness regarding breast cancer and personalized medicines spreads....